Encore un effort !

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Déjà Q: Encore! Un Petit IBE

We present an identity-based encryption (IBE) scheme in composite-order bilinear groups with essentially optimal parameters: the ciphertext overhead and the secret key are one group element each and decryption requires only one pairing. Our scheme achieves adaptive security and anonymity under standard decisional subgroup assumptions as used in Lewko and Waters (TCC ’10). Our construction relie...

متن کامل

Encore un outil de découverte de correspondances entre schémas XML ?

In this paper, we present YAM, a schema matcher factory. YAM (Yet Another Matcher) is not (yet) another schema matching system as it enables the generation of a la carte schema matchers according to user requirements. These requirements include a preference for recall or precision and a training data set (a set of expert correspondences or a domain of interest). YAM uses a knowledge base that i...

متن کامل

Interactive Construction of EnCOrE

One of the major challenges of current ITS research is scaling up to real world learning scenarios. Another one, strictly interwoven, is to integrate human learning with other human activities, such as constructing theories or performing experiments, as it is the case in e-Science. The paper describes the results of the first phase of an ambitious project: EnCOrE for building and using an Encyc...

متن کامل

EnCoRe: Ensuring Consent and Revocation

We introduce refinement checking for privacy policies expressed in P3P and XACML. Our method involves a translation of privacy policies to a set of process specifications in CSP, which describe how the privacy policy is enforced. The technique is described through an example involving medical data collected by a biobank.

متن کامل

FDA Reform: Déjà Vu Encore

The Food and Drug Administration (FDA) creates the climate for the development of new drugs and clinical research. A 30 year struggle to bring drugs to the market more rapidly culminated in the 1992 Prescription Drug User Fee Act (PDUFA). While drug review times have shortened, concerns about drug safety possibly associated with more rapid reviews have led FDA and Congress to tighten safety req...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Mélanges de la Casa de Velázquez

سال: 2017

ISSN: 0076-230X,2173-1306

DOI: 10.4000/mcv.7944